RNS Number:2123K
Fulcrum Pharma PLC
22 April 2003


For Immediate Release                                              22 April 2003


                               Fulcrum Pharma Plc
                           Notice of Interim Results

Fulcrum Pharma plc (LSE: FUL), the independent, drug development company, will
announce Interim Results for the six months ended 28 February 2003 on Thursday,
15 May 2003.

An analyst meeting will be held at the offices of Buchanan Communications, 107
Cheapside, EC2V 6DN at 10.30am.

For further information please contact:

Nicola How / Louise Bolton
Buchanan Communications                                            020 7466 5000


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NORBLLFLXZBLBBX